Agne Paner to Infusions, Intravenous
This is a "connection" page, showing publications Agne Paner has written about Infusions, Intravenous.
Connection Strength
0.043
-
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma. Invest New Drugs. 2020 10; 38(5):1448-1453.
Score: 0.043